irinotecan has been researched along with carbachol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hamada, N; Ikari, A; Kakinoki, B; Sakai, H; Sato, T; Takeguchi, N; Yasue, M | 1 |
2 other study(ies) available for irinotecan and carbachol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoxepins; Camptothecin; Carbachol; Chloride Channels; Chlorides; Colon; Cyclooxygenase Inhibitors; Dinoprostone; Female; Imidazoles; Indomethacin; Intestinal Mucosa; Irinotecan; Membrane Potentials; Nitrobenzoates; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, Thromboxane; Tetrodotoxin; Thromboxane A2; Thromboxane-A Synthase | 1997 |